MA38794A1 - New immunotherapy against multiple tumors, such as lung cancer, including large cell lung cancer - Google Patents
New immunotherapy against multiple tumors, such as lung cancer, including large cell lung cancerInfo
- Publication number
- MA38794A1 MA38794A1 MA38794A MA38794A MA38794A1 MA 38794 A1 MA38794 A1 MA 38794A1 MA 38794 A MA38794 A MA 38794A MA 38794 A MA38794 A MA 38794A MA 38794 A1 MA38794 A1 MA 38794A1
- Authority
- MA
- Morocco
- Prior art keywords
- lung cancer
- present
- relates
- large cell
- against multiple
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 206010023774 Large cell lung cancer Diseases 0.000 title 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 title 1
- 238000009169 immunotherapy Methods 0.000 title 1
- 201000005202 lung cancer Diseases 0.000 title 1
- 201000009546 lung large cell carcinoma Diseases 0.000 title 1
- 208000020816 lung neoplasm Diseases 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 4
- 230000005975 antitumor immune response Effects 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 229960005486 vaccine Drugs 0.000 abstract 2
- 238000002619 cancer immunotherapy Methods 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 abstract 1
- 230000001024 immunotherapeutic effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 210000004881 tumor cell Anatomy 0.000 abstract 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
La présente invention concerne des peptides, des acides nucléiques et des cellules pour utilisation dans des procédés immunothérapeutiques. En particulier, la présente invention concerne l'immunothérapie du cancer. La présente invention concerne en outre des épitopes peptidiques de lymphocytes t cytotoxiques (ctl), seuls ou en combinaison avec d'autres peptides associés à des tumeurs qui servent de substances pharmaceutiques actives de compositions de vaccin qui stimulent des réponses immunitaires antitumorales. La présente invention concerne plus de 70 nouvelles séquences peptidiques et leurs variants dérivés de molécules hla de classe i et des molécules hla de classe ii de cellules tumorales humaines qui peuvent être utilisées dans des compositions de vaccin pour induire des réponses immunitaires antitumorales.The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to cancer immunotherapy. The present invention further relates to cytotoxic t cell peptide epitopes (ct1), alone or in combination with other tumor-associated peptides that serve as active pharmaceutical substances of vaccine compositions that stimulate antitumor immune responses. The present invention relates to more than 70 novel peptide sequences and variants thereof derived from hla class I molecules and hla class II human tumor cell molecules that can be used in vaccine compositions to induce antitumor immune responses.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1313987.8A GB201313987D0 (en) | 2013-08-05 | 2013-08-05 | Novel immunotherapy against several tumors, such as lung cancer including NSCLC |
| PCT/EP2014/066755 WO2015018805A1 (en) | 2013-08-05 | 2014-08-04 | Novel immunotherapy against several tumors, such as lung cancer, including nsclc |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MA38794A1 true MA38794A1 (en) | 2017-12-29 |
| MA38794B1 MA38794B1 (en) | 2019-04-30 |
Family
ID=49224173
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA38794A MA38794B1 (en) | 2013-08-05 | 2014-08-04 | New immunotherapy against multiple tumors, such as lung cancer, including large cell lung cancer |
| MA42333A MA42333A1 (en) | 2013-08-05 | 2014-08-04 | New immunotherapy against multiple tumors, such as lung cancer, including large cell lung cancer |
| MA46798A MA46798B1 (en) | 2013-08-05 | 2014-08-04 | New immunotherapy against several tumors, such as lung cancer, including large cell lung cancer |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA42333A MA42333A1 (en) | 2013-08-05 | 2014-08-04 | New immunotherapy against multiple tumors, such as lung cancer, including large cell lung cancer |
| MA46798A MA46798B1 (en) | 2013-08-05 | 2014-08-04 | New immunotherapy against several tumors, such as lung cancer, including large cell lung cancer |
Country Status (3)
| Country | Link |
|---|---|
| AR (1) | AR113131A2 (en) |
| GB (1) | GB201313987D0 (en) |
| MA (3) | MA38794B1 (en) |
-
2013
- 2013-08-05 GB GBGB1313987.8A patent/GB201313987D0/en not_active Ceased
-
2014
- 2014-08-04 MA MA38794A patent/MA38794B1/en unknown
- 2014-08-04 MA MA42333A patent/MA42333A1/en unknown
- 2014-08-04 MA MA46798A patent/MA46798B1/en unknown
-
2018
- 2018-09-21 AR ARP180102711A patent/AR113131A2/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MA42333A1 (en) | 2019-05-31 |
| MA46798B1 (en) | 2022-10-31 |
| GB201313987D0 (en) | 2013-09-18 |
| MA46798A1 (en) | 2022-02-28 |
| MA38794B1 (en) | 2019-04-30 |
| AR113131A2 (en) | 2020-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA39907B1 (en) | New immunotherapy against several tumors, blood, including acute myeloid leukemia (lam) | |
| MA41879A1 (en) | Novel peptides and peptide combination for use in immunotherapy against prostate cancer and other cancers | |
| MA42021A1 (en) | Novel peptides and peptide combination for use in immunotherapy against small cell lung cancer and other cancers | |
| MA40813A1 (en) | Novel peptides and combination of peptides for use in immunotherapy against various tumors | |
| MA40794A1 (en) | Novel peptides and combinations of peptides and scaffolds for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers | |
| MA41717A1 (en) | Novel peptides and peptide combination for use in immunotherapy against epithelial ovarian cancer and other cancers | |
| MA42072A1 (en) | Novel peptides and peptide combination for use in immunotherapy against cll and other cancers | |
| MA43719B1 (en) | PEPTIDE FOR USE IN IMMUNOTHERAPY AGAINST NON-SMALL CELL LUNG CANCER AND SMALL CELL LUNG CANCER | |
| MA43466A1 (en) | Treatments for uterine cancer | |
| MA41521A1 (en) | Novel cell epitopes and new combination of cell epitopes for use in immunotherapy of myeloma and other cancers | |
| MA42020A1 (en) | Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers | |
| MA41237B1 (en) | New peptides and peptide combinations for use in immunotherapy against hepatocellular carcinoma (chc) and other cancers | |
| MA43075A1 (en) | Novel peptides and combination of peptides for use in immunotherapy against non-Hodgkin lymphoma and other cancers | |
| MA43490A1 (en) | New peptides and combination of peptides for use in immunotherapy against various cancers | |
| MA41520B2 (en) | New peptides and peptide combination for use in immunotherapy against ovarian cancer and other cancers | |
| MA41393A1 (en) | Novel peptides and peptide combinations and scaffolds formed therefor for use in immunotherapy against colorectal carcinoma (crc) and other cancers | |
| MA42294B1 (en) | New peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers | |
| MA40713A1 (en) | Novel Peptides and Peptide Combination for Use in the Immunotherapy of Pancreatic Cancer and Other Cancers | |
| MA44551A1 (en) | Novel peptides and novel combination of peptides for use in immunotherapy, and methods for generating scaffolds for use against pancreatic cancer and other cancers | |
| MA43460A1 (en) | Novel peptides, peptide combinations and carriers for use in the immunotherapeutic treatment of various cancers | |
| MA48487B1 (en) | New peptides and peptide combination for use in immunotherapy against hepatocellular carcinoma (hcc) and other cancers | |
| MA38794B1 (en) | New immunotherapy against multiple tumors, such as lung cancer, including large cell lung cancer | |
| MA42022A1 (en) | Novel peptides, peptide combinations and carriers for use in the immunotherapeutic treatment of various cancers | |
| MA41664A1 (en) | Novel peptides and novel peptide combination for use in immunotherapy, and methods for generating scaffolds for use against pancreatic cancer and other cancers |